Medicsight PLC is an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection and diagnosis of disease. Medicsight’s ColonCAD™ solution automatically highlights suspicious areas on computerised tomography colonography (CTC) scans, helping radiologists to identify, measure and analyse polyps and indicators of potential disease. Medicsight’s ColonCAD™ software has been developed using a large, population diverse database of verified patient CT colonography scan data. ColonCAD™ is seamlessly integrated with the advanced 3D visualisation workstation of several industry-leading imaging equipment partners. As part of their on-going commitment to radiologists and to improve the early detection of colorectal cancer, Medicsight have developed an automated insufflator for use with CT colonography procedures. MedicCO2LON 1.0 is a customisable, automated CO2 insufflator developed in consultation with leading CTC centres worldwide. The unit is designed with a unique LCD touch-screen for ease of use, supporting clinicians in achieving optimal colonic distension whilst minimising patient discomfort during CT-colonography procedures.
Looking for a particular Medicsight employee's phone or email?
The Medicsight annual revenue was $5.6 million in 2026.
Medicsight is based in London, Greater London.
The NAICS codes for Medicsight are [518, 5182, 51].
The SIC codes for Medicsight are [73, 737].